Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.49 CAD | +5.06% | +1.63% | +492.86% |
01:35pm | Medicenna to Present Clinical Update on MDNA11 ABILITY-1 Trial at Sachs Oncology Innovation Forum | MT |
May. 13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
Business Summary
Number of employees: 16
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11-09-30 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
David Hyman
DFI | Director of Finance/CFO | - | Feb. 13 |
Delphine Davan
IRC | Investor Relations Contact | - | 23-08-13 |
Minh To
PRN | Corporate Officer/Principal | - | 23-08-13 |
Eamonn Peters
PRN | Corporate Officer/Principal | - | 23-08-13 |
Evelyn Pau
PRN | Corporate Officer/Principal | - | 23-08-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 19-09-23 |
Albert Beraldo
BRD | Director/Board Member | - | 16-11-21 |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
Founder | - | 11-09-30 | |
Jack Geltosky
BRD | Director/Board Member | 78 | 20-09-29 |
John Sampson
BRD | Director/Board Member | - | 21-09-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,778,857 | 53,700,082 ( 71.81 %) | 0 | 71.81 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+492.86% | 130M | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- MDNA Stock
- Company Medicenna Therapeutics Corp.